Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Microbiome Transplant in Adult Atopic Dermatitis
NCT03158012Phase 1Completed
- Sponsor
- University of California, San Diego
- Start
- Apr 2016
- Primary completion
- Dec 2017
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of autologous CoNS-AM+ in atopic dermatitis (AD) (2 arms), sponsored by University of California, San Diego. Primary endpoint: Relative Abundance of Staphylococcus Aureus Compared to Baseline at 24 hours. Started Apr 2016; status: completed.
02
Drugs
autologous CoNS-AM+
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT03158012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03158012.